Vildabet met

Overview

Vildabet Met is a combination oral antidiabetic medication containing Vildagliptin and Metformin. Vildagliptin is a DPP-4 inhibitor that enhances the body’s incretin system to increase insulin release and decrease glucagon secretion, while Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity.

It is prescribed for type 2 diabetes mellitus to improve glycemic control in patients not adequately managed by diet, exercise, or monotherapy.

⚖️ Strength/Dosage Form:

Tablet (common strengths: Vildagliptin 50 mg + Metformin 500 mg / 850 mg / 1000 mg)

Oral administration

✅ Indication:

Management of type 2 diabetes mellitus

Patients requiring dual therapy for better glycemic control

Adjunct to diet and exercise

⚠️ Note:

Use under medical supervision

Monitor blood glucose regularly

Not indicated for type 1 diabetes or diabetic ketoacidosis